Tessera Therapeutics
Yashvi Bhavsar is a skilled professional in the biotechnology and chemical engineering fields, currently serving as a Senior Research Associate at Tessera Therapeutics since June 2021. Prior to this role, Yashvi worked as a Research Associate II in mRNA Process Development at the National Center for Therapeutics Manufacturing and was involved in instructing hands-on training programs. Previous experience includes conducting research as an intern on COVID-19 projects, where Yashvi managed cell cultures to support lab experiments. Additional roles include Graduate Student Researcher at Texas A&M University, focusing on protein purification and prior internships at Emcure Pharmaceuticals Limited and ONGC. Yashvi holds a Master's degree in Biotechnology from Texas A&M University and a Bachelor of Technology in Chemical Engineering from Malaviya National Institute of Technology Jaipur.
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.